Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.
Philippe RochigneuxAaron E LisbergAlejandro GarciaSamuel GranjeaudAnne MadroszykStéphane FattoriAnthony GoncalvesRaynier DevillierPauline MabyNassim SalemLaurent GorvelBrice ChanezJaklin GukasyanJames CarrollJonathan Wade GoldmanAnne-Sophie ChretienDaniel OliveEdward B GaronPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
As this immune monitoring is easy in routine practice, we anticipate our findings may improve prediction of ICI benefit in patients with advanced NSCLC.